Company:  FLUIDIGM CORP (FLDM)
Form Type:  8-K
Filing Date:  2/10/2020 
CIK:  0001162194 
Address:  7000 SHORELINE COURT
SUITE 100
 
City, State, Zip:  SOUTH SAN FRANCISCO, California 94080 
Telephone:  (650) 266-6000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.40  
Change: 
-0.11 (-1.29%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$599.06M
Trade FLDM now with

© 2020  
Description of Business
Fluidigm is a global company that improves life through comprehensive health insight. Our innovative patented technologies and multi-omic tools are used by researchers to reveal meaningful insights into health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. We create, manufacture, and market a range of products and services, including instruments, reagents and software that are used by researchers worldwide. Our focus is on the most pressing needs in translational and clinical research, including cancer, immunology and immunotherapy. We use proprietary CyTOF® and microfluidics technologies to develop innovative end-to-end solutions that have the flexibility required to meet the needs of translational research and the robustness to support high-impact clinical research studies. Our mass cytometry Helios(TM) system deeply profiles cell phenotype and function.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02. Results of Operations and Financial Condition.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURE
  EXHIBIT 99.1
    INCOME STATEMENT
    BALANCE SHEET
    CASH FLOW